These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 25535078)

  • 1. Emerging biomarkers in heart failure and cardiac cachexia.
    Loncar G; Omersa D; Cvetinovic N; Arandjelovic A; Lainscak M
    Int J Mol Sci; 2014 Dec; 15(12):23878-96. PubMed ID: 25535078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel heart failure biomarkers: why do we fail to exploit their potential?
    Piek A; Du W; de Boer RA; Silljé HHW
    Crit Rev Clin Lab Sci; 2018 Jun; 55(4):246-263. PubMed ID: 29663841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac cachexia: hic et nunc: "hic et nunc" - here and now.
    Loncar G; Springer J; Anker M; Doehner W; Lainscak M
    Int J Cardiol; 2015 Dec; 201():e1-12. PubMed ID: 26545926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serial Echocardiographic Characteristics, Novel Biomarkers and Cachexia Development in Patients with Stable Chronic Heart Failure.
    Gaggin HK; Belcher AM; Gandhi PU; Ibrahim NE; Januzzi JL
    J Cardiovasc Transl Res; 2016 Dec; 9(5-6):429-431. PubMed ID: 27631883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive value of biomarkers in patients with heart failure.
    Tousoulis D; Oikonomou E; Siasos G; Chrysohoou C; Charakida M; Trikas A; Siasou Z; Limperi M; Papadimitriou ED; Papavassiliou AG; Stefanadis C
    Curr Med Chem; 2012; 19(16):2534-47. PubMed ID: 22489715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucose Homeostasis, Pancreatic Endocrine Function, and Outcomes in Advanced Heart Failure.
    Melenovsky V; Benes J; Franekova J; Kovar J; Borlaug BA; Segetova M; Tura A; Pelikanova T
    J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28784650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [ANMCO/ELAS/SIBioC Consensus document: Recommendations for the use of cardiac biomarkers in heart failure patients].
    Aspromonte N; Gulizia MM; Clerico A; Di Tano G; Emdin M; Feola M; Iacoviello M; Latini R; Mortara A; Valle R; Misuraca G; Passino C; Masson S; Aimo A; Ciaccio M; Migliardi M
    G Ital Cardiol (Rome); 2016 Sep; 17(9):615-656. PubMed ID: 27869886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarkers and diagnostics in heart failure.
    Gaggin HK; Januzzi JL
    Biochim Biophys Acta; 2013 Dec; 1832(12):2442-50. PubMed ID: 23313577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac Cachexia Revisited: The Role of Wasting in Heart Failure.
    Valentova M; Anker SD; von Haehling S
    Cardiol Clin; 2022 May; 40(2):199-207. PubMed ID: 35465894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations.
    Mueller C; McDonald K; de Boer RA; Maisel A; Cleland JGF; Kozhuharov N; Coats AJS; Metra M; Mebazaa A; Ruschitzka F; Lainscak M; Filippatos G; Seferovic PM; Meijers WC; Bayes-Genis A; Mueller T; Richards M; Januzzi JL;
    Eur J Heart Fail; 2019 Jun; 21(6):715-731. PubMed ID: 31222929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormonal consequences and prognosis of chronic heart failure.
    Attanasio P; Anker SD; Doehner W; von Haehling S
    Curr Opin Endocrinol Diabetes Obes; 2011 Jun; 18(3):224-30. PubMed ID: 21494135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble ST2 proteins in male cachectic patients with chronic heart failure.
    Sobieszek G; Powrózek T; Jaroszyński A; Skwarek-Dziekanowska A; Rahnama-Hezavah M; Małecka-Massalska T
    Nutr Metab Cardiovasc Dis; 2021 Mar; 31(3):886-893. PubMed ID: 33549461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between tumor necrosis factor-α, brain natriuretic peptide and atrial natriuretic peptide in patients with chronic heart failure.
    Vaz Pérez A; Doehner W; von Haehling S; Schmidt H; Zimmermann AV; Volk HD; Anker SD; Rauchhaus M
    Int J Cardiol; 2010 May; 141(1):39-43. PubMed ID: 19155075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adropin and Irisin in Patients with Cardiac Cachexia.
    Kalkan AK; Cakmak HA; Erturk M; Kalkan KE; Uzun F; Tasbulak O; Diker VO; Aydin S; Celik A
    Arq Bras Cardiol; 2018 Jul; 111(1):39-47. PubMed ID: 29972412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A combined bioinformatics, experimental and clinical approach to identify novel cardiac-specific heart failure biomarkers: is Dickkopf-3 (DKK3) a possible candidate?
    Piek A; Suthahar N; Voors AA; de Boer RA; Silljé HHW
    Eur J Heart Fail; 2020 Nov; 22(11):2065-2074. PubMed ID: 32809235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Established and Emerging Roles of Biomarkers in Heart Failure.
    Ibrahim NE; Januzzi JL
    Circ Res; 2018 Aug; 123(5):614-629. PubMed ID: 30355136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The emerging role of Galectin-3 and ST2 in heart failure: practical considerations and pitfalls using novel biomarkers.
    Karayannis G; Triposkiadis F; Skoularigis J; Georgoulias P; Butler J; Giamouzis G
    Curr Heart Fail Rep; 2013 Dec; 10(4):441-9. PubMed ID: 24142671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leptin in heart failure.
    Barbosa-Ferreira JM; Fernandes F; Dabarian A; Mady C
    Expert Opin Med Diagn; 2013 Jan; 7(1):113-7. PubMed ID: 23530847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natriuretic peptides and NGAL in heart failure: does a link exist?
    Palazzuoli A; Beltrami M; Pellegrini M; Nuti R
    Clin Chim Acta; 2012 Nov; 413(23-24):1832-8. PubMed ID: 22820397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent insights on chronic heart failure, cachexia and nutrition.
    Miján-de-la-Torre A
    Curr Opin Clin Nutr Metab Care; 2009 May; 12(3):251-7. PubMed ID: 19363338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.